InvestorsHub Logo
Followers 21
Posts 767
Boards Moderated 0
Alias Born 04/30/2020

Re: peafunke post# 110158

Friday, 06/11/2021 5:30:00 PM

Friday, June 11, 2021 5:30:00 PM

Post# of 161623
Hello this is especially for those who would spread false narratives. The unvaccinated have nothing to do with the coming ADE vaccine breakthrough variants, sorry that one is on the Vaxxers! Let me state that the dumbest thing in human history will have been to try to manipulate and stop a Lab generated virus.
Time will show that to be true.

To your magnet comments... enjoy that CROW, like a little salt with that?

Now this from another company I'm invested in. "Check out #3" I knew it, I knew it.

William A. Hartman, Halberd's Chairman, President & CEO, commented, "Halberd now has four antibodies specifically targeting the SARS-CoV-2 Spike Protein antigen.
JACKSON CENTER, PA / ACCESSWIRE / June 7, 2021
Hartman continued, "Together with our patented extracorporeal treatment process, we believe we have an effective method of treating viruses and bacterial infections which are resistant to conventional therapies. Halberd's strategy continues to follow our process road map consisting of:
1. Identifying a target antigen;
2. Creating patentable antibodies with high binding affinity against the target antigen;
3. Conjugating these antibodies with metallic nanoparticles (moieties) through a patent-pending process;
4. Applying Halberd's patented extracorporeal process of eradicating the moiety-antigen complex in bodily fluids through the patent-pending process of exposing it to radiofrequency waves or laser emissive energy;
5. Conducting animal testing to establish the safety and efficacy of our revolutionary process for the eradication of diseases."
"We have successfully completed steps 1, 2, & 3. We are in the process of executing Step 4 for effectiveness against the SARS-Cov-2 spike protein and E. coli bacteria. This will be followed by executing animal testing, for which the groundwork is already being laid."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TPTW News